Clinical Trial

the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The investigators evaluated the impact of AF on different subtypes of post-alteplase hemorrhagic transformation of brain infarction.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-21.
Trial Details
NCT Number NCT06653946
Lead Sponsor Kafrelsheikh University
Conditions Ischemic Stroke, Alteplase Adverse Reaction
Enrollment 716 participants
Start Date 2022-07-01
Primary Completion 2024-07-01 (estimated)
Study Completion 2024-11-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-29